Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sulfoxide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN121362155A reveals efficient iron-catalyzed sulfoxidation. Offers high ee, cost reduction, and scalable supply for pharma intermediates.
Patent CN116981659A details a novel Fe-catalyzed route for chiral sulfoxides, offering high purity and cost reduction in pharmaceutical intermediate manufacturing without chiral HPLC.
Advanced oxidation method for 4,4'-dichlorodiphenyl sulfone ensures high purity and recyclable catalysts. Delivers substantial cost reduction in polymer additive manufacturing and supply chain reliability.
Patent CN105541685B reveals high-yield iridium-catalyzed trifluoromethylation. Delivers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN114657580B reveals electrocatalytic method for methyl sulfoxide derivatives offering green synthesis and supply chain advantages for pharmaceutical intermediates.
Patent CN105777665B reveals a novel Calcipotriol intermediate synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel two-step synthesis of axially chiral bissulfoxide ligands via oxidative coupling. High enantioselectivity for Rh-catalyzed additions. Reliable supply chain partner.
Patent CN110483345A enables green selective oxidation of thioethers. Discover cost-effective pharmaceutical intermediate manufacturing with mild visible light conditions.
Patent CN104560905B reveals green enzymatic route for chiral sulfoxides. Enables cost reduction and sustainable supply chain for pharmaceutical intermediates manufacturing globally.
Advanced preparation method for S-type chiral sulfoxide compounds via vanadium-catalyzed oxidation. Ensures high purity for Ticagrelor intermediate manufacturing and supply chain stability.
Patent CN101434609B details a tungstate-catalyzed oxidation of 6-APA. This green process offers high yield and safety for reliable pharmaceutical intermediate supply chains.
Patent CN107488639A reveals a novel toluene monooxygenase for high-purity chiral sulfoxide production. Discover green biocatalytic advantages for pharmaceutical supply chains.
Patent CN103319417A details a novel synthesis for Triclabendazole Sulfoxide, offering higher purity and reduced environmental impact for veterinary drug manufacturing.
Patent CN113461578B reveals green aqueous synthesis using ytterbium catalyst. Reduces cost and lead time for high-purity pharmaceutical intermediates and fine chemical manufacturing.
Novel two-step route using bis-ketal glucose enables high-purity chiral monomers for reusable polymer-supported asymmetric catalysis applications.
Patent CN104892575A enables high-purity chiral imidazole sulfoxide production with simplified processes, offering significant supply chain and cost advantages for global buyers.
Patent CN114349795A reveals rapid synthesis of tetra dimethyl sulfoxide ruthenium chloride. Achieve high purity and yield with significantly reduced reaction time for scalable production.
Patent CN113754605B discloses high-ee nitrogen ligands for thioether oxidation. Enables cost reduction in chiral chemical manufacturing and reliable supply.
Novel electrochemical route for chloroethyl sulfoxide eliminates metal catalysts, offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Patent CN110746428A details a novel asymmetric oxidation route for high-purity R-type chiral sulfoxide, offering significant cost reduction in API manufacturing and improved supply chain reliability.